SOD2 knockdown in liver cancer cell lines overexpressing NEAT1v1 activated MEK and ERK as well as P38MAPK and JNK and sensitized cells to sorafenib and lenvatinib (Figure 4C,D and Figure S1C). The gene discussed is MAPK8; the disease is liver cancer.